Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Parenteral Iron Supplementation After Gastrointestinal Bleeding in Subjects Over 65

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients aged over 65 hospitalized for upper or lower GI bleeding with positve outcome during hospitalization without surgery, and with persistent anaemia (Hb \<11g/dL),~2. Signed informed consent,~3. Patients with National Health Insurance,~Exclusion Criteria:~1. Uncontrolled haemorrhage defined by any new externalizing and / or a decrease of haemoglobin and haematocrit levels,~2. GI bleeding related to portal hypertension or malignancy,~3. The absence of anaemia,~4. Cancer evolution,~5. Patient under guardianship, curatorship or unable to supply consent,~6. Iron overload,~7. History of asthma~8. History of eczema~9. Hypersensitivity to any component~10. Decompensated liver cirrhosis~11. Infection during treatment or uncontrolled infection 12 Rheumatoid arthritis~13. Acute renal failure

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ferinject 1000 mg (Type: EXPERIMENTAL): Intravenous Administration of 1000 mg of ferinject Volume of infusion : 250 mL
- Placebo (Type: PLACEBO_COMPARATOR): Intravenous administration of 250 ml of sodium chlorure 0.9 %

Based on this trial design, predict the completion outcome and termination type (if applicable).